No Data
No Data
Janux Therapeutics Analyst Ratings
Stifel Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $70
Cantor Fitzgerald Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $100
Analysts' Opinions Are Mixed on These Healthcare Stocks: CVS Health (CVS), Amicus (FOLD) and Janux Therapeutics Inc (JANX)
Janux Therapeutics Inc (JANX) Receives a Buy From Cantor Fitzgerald
H.C. Wainwright Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $63